Arquivamento - Art. 36 §1° da LPI
#11.2
08/05/2025
RPI 2848
Application data
Number
112019021445Type
Filing
Publication
PCT
US2018027514 The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 08/05/2025. We update with every new RPI gazette, published weekly.
Applicants
ONCONOVA THERAPEUTICS, INC
US
Inventors
M. M. (pessoa física)
US
IPC Classification
Priority claims
US
15/688,320 · 08/28/2017
US
62/485,355 · 04/13/2017
US
PCT/US17/48890 · 08/28/2017
Abstract
As composições farmacêuticas de (E)-2,4,6-trimetóxiestiril-3-[(carbóximetil)amino]-4-metóxibenzilsulfona e seus sais aceitáveis sob o ponto de vista farmacêutico são descritas, bem como métodos de uso e um regime de doses de (E)-2,4,6-trimetóxiestiril-3-[(carbóximetil)amino]-4-metóxibenzilsulfona, sal de sódio para reduzir a incidência de toxicidade urotelial.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
08/05/2025
RPI 2848
#6.1
04/24/2025
RPI 2833
#6.23
05/24/2022
RPI 2681
#15.35
10/19/2021
RPI 2650
#1.3
05/05/2020
RPI 2574
#1.1
10/22/2019
RPI 2546
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.